Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus rating of “Moderate Buy” from the twenty-three research firms that are currently covering the firm, Marketbeat Ratings reports. Eleven research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $275.75.

Several equities research analysts have commented on ALAB shares. Royal Bank Of Canada boosted their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Barclays raised their price target on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Finally, UBS Group raised their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research note on Monday, June 29th.

Insider Activity

In other Astera Labs news, Director Bethany Mayer sold 686 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director directly owned 5,550 shares in the company, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,700,432 shares of company stock valued at $449,062,723. Company insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds have recently bought and sold shares of ALAB. Vanguard Group Inc. boosted its holdings in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares during the last quarter. Atreides Management LP raised its holdings in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. State Street Corp raised its holdings in shares of Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC lifted its position in Astera Labs by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. Finally, Fred Alger Management LLC lifted its position in Astera Labs by 25.5% during the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Down 5.0%

Shares of ALAB opened at $303.62 on Friday. The business’s 50 day moving average price is $349.32 and its 200-day moving average price is $220.59. Astera Labs has a 52 week low of $96.79 and a 52 week high of $499.48. The stock has a market cap of $52.04 billion, a P/E ratio of 205.15, a P/E/G ratio of 3.42 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the business posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs will post 1.88 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.